SPAIN LACKS CONCRETE HEALTH POLICY

10 May 1992

The three main issues affecting health care in Spain last year were: the setting up of the Abril commission that analyzed and evaluated the country's national health care system; the continuation of the process of transferring the services of Insalud, the Spanish Institute of Health, to the autonomous communities; and the ministerial change.

The Abril commission (Marketletters passim) came up with a proposal for health reform that would result in changes in organization, management and financing along the lines of health care systems currently in existence in other European countries such as the UK, the Netherlands and Sweden.

This would mean the introduction of competition, and more responsibility for those professionals involved in the health care services, explained Juan Manuel Cabases Hita, professor at the department of economics at Navarra University, as he looked back at the year in an article that appeared in the Spanish magazine, Economistas, and which was reproduced in the Spanish financial daily, Cinco Dias.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight